Real-world evaluation of multimodal treatment practice in older oesophageal cancer patients

医学 模式治疗法 癌症 新辅助治疗 内科学 队列 逻辑回归 化疗 放化疗 外科 肿瘤科 乳腺癌
作者
Tianzheng Shen,Yajie Zhang,Yuqin Cao,Hong Zhang,Hecheng Li
出处
期刊:European Journal of Cardio-Thoracic Surgery [Oxford University Press]
标识
DOI:10.1093/ejcts/ezae329
摘要

Abstract OBJECTIVES Elderly-specific data for multimodal treatment of oesophageal cancer (EC) is lacking. This study aimed to evaluate the safety and efficacy of multimodal treatment in older EC patients and to compare the impact of neoadjuvant chemotherapy (NCT) and neoadjuvant chemoradiotherapy (NCRT). METHODS Patients diagnosed with oesophageal squamous cell carcinoma or adenocarcinoma who received NCT/NCRT were identified in the National Cancer Database (NCDB, 2004–2015). First, we compared baseline and post-treatment characteristics between younger (<70 years) and older patients (≥70 years). Logistic regression was used to investigate risk factors of postoperative mortality. Second, we evaluated the effect of neoadjuvant chemotherapy on postoperative mortality and overall survival in the older cohort. Inverse probability of treatment weights (IPTW) and multivariable analyses were used to compensate for differences in baseline covariates. RESULTS We first compared outcomes of neoadjuvant therapy plus oesophagectomy in 14778 eligible EC patients. The older group experienced higher rates of postoperative mortality at 30 days (5.8%) and 90 days (13.5%) compared to younger patients. Postoperative mortality was significantly related to the Charlson-Deyo score and treatment-related factors including NAT type and minimally invasive technique. Second, among the 3,141 older patients (with a median follow-up of 57.8 months and 2029 deaths), those receiving NCT obtained significantly lower postoperative mortality and improved overall survival compared with NCRT (IPTW-Adjusted P = 0.05; HR, 0.85; 95% Cl, 0.72–0.99). CONCLUSIONS Neoadjuvant therapy plus oesophagectomy carries increased short-term mortality risk in older EC patients. NCT in older EC patients showed lower postoperative mortality but no statistically significant differences in overall survival with a point estimate favoring NCT compared to the NCRT group, making NCT a potential option for consideration in specific cases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
肖礼成完成签到,获得积分10
3秒前
淡然子轩发布了新的文献求助10
6秒前
10秒前
Cheny完成签到 ,获得积分10
10秒前
11秒前
周凡淇发布了新的文献求助10
11秒前
情怀应助室内设计采纳,获得10
11秒前
东方天奇发布了新的文献求助10
12秒前
粱乘风发布了新的文献求助10
13秒前
天真大神完成签到,获得积分10
13秒前
oyb完成签到,获得积分10
15秒前
whisper发布了新的文献求助10
16秒前
16秒前
风中听枫完成签到 ,获得积分10
16秒前
17秒前
19秒前
郝瑞之发布了新的文献求助10
20秒前
华仔应助Wd采纳,获得10
20秒前
视野胤发布了新的文献求助10
21秒前
wen发布了新的文献求助10
23秒前
24秒前
24秒前
大模型应助郝瑞之采纳,获得10
27秒前
shinysparrow应助赫连人杰采纳,获得200
27秒前
科研通AI2S应助安静的天思采纳,获得10
27秒前
28秒前
29秒前
Wd完成签到,获得积分10
29秒前
Wd发布了新的文献求助10
34秒前
赘婿应助Ethan采纳,获得10
34秒前
34秒前
35秒前
Orange应助gggyyy采纳,获得30
37秒前
37秒前
橙花发布了新的文献求助10
41秒前
Qing完成签到,获得积分10
43秒前
43秒前
45秒前
orixero应助科研通管家采纳,获得10
45秒前
高分求助中
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Handbook of Qualitative Cross-Cultural Research Methods 600
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3139211
求助须知:如何正确求助?哪些是违规求助? 2790129
关于积分的说明 7794004
捐赠科研通 2446563
什么是DOI,文献DOI怎么找? 1301236
科研通“疑难数据库(出版商)”最低求助积分说明 626124
版权声明 601109